Your browser doesn't support javascript.
loading
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.
Gao, Y; Weenink, B; van den Bent, M J; Erdem-Eraslan, L; Kros, J M; Sillevis Smitt, Pae; Hoang-Xuan, K; Brandes, A A; Vos, M; Dhermain, F; Enting, R; Ryan, G F; Chinot, O; Ben Hassel, M; van Linde, M E; Mason, W P; Gijtenbeek, J M M; Balana, C; von Deimling, A; Gorlia, Th; Stupp, R; Hegi, M E; Baumert, B G; French, P J.
Affiliation
  • Gao Y; Department of Neurology, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
  • Weenink B; Department of Neurology, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
  • van den Bent MJ; Department of Neurology, Daniel Den Hoed Cancer Center, 3075 EA, Rotterdam, The Netherlands.
  • Erdem-Eraslan L; Department of Neurology, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
  • Kros JM; Department of Pathology, Erasmus University Medical Center, 3000CA, Rotterdam.
  • Sillevis Smitt P; Department of Neurology, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
  • Hoang-Xuan K; APHP Pitié-Salpêtrière, Sorbonne Universités, UPMC, ICM, UMRS, 1127, Paris, France.
  • Brandes AA; Ospedale Bellaria, Bologna, Italy.
  • Vos M; Med Ctr Haaglanden, The Netherlands.
  • Dhermain F; I. Gustave Roussy, Villejuif, France.
  • Enting R; UMCG and University of Groningen, Groningen, The Netherlands.
  • Ryan GF; Peter MacCallum Cancer Center, Melbourne, Australia.
  • Chinot O; Aix Marseille, Université, APHM La Timone, Marseille, France.
  • Ben Hassel M; Centre Eugène Marquis, Rennes, France.
  • van Linde ME; VU University Medical Center, Academic Medical Center, Amsterdam, The Netherlands.
  • Mason WP; Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
  • Gijtenbeek JMM; Radboud University Medical Center Nijmegen, The Netherlands.
  • Balana C; ICO Badalona Hospital, Germans Trias I Pujol, Barcelona, Spain.
  • von Deimling A; German Cancer Consortium (DKTK), CCU Neuropathology German Cancer Research Center (DKFZ), Department Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Gorlia T; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
  • Stupp R; Neuroscience Research Centre, CHUV, Lausanne, Switzerland.
  • Hegi ME; Department of Clinical Neurosciences, Lausanne University Hospital, Lausanne, Switzerland.
  • Baumert BG; Dept. of Radiation-Oncology, Paracelsus Clinic Osnabrueck, University of Muenster, Germany; Maastricht University Medical Centre, GROW (School for Oncology), Maastricht, The Netherlands.
  • French PJ; Department of Neurology, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands. Electronic address: p.french@erasmusmc.nl.
Eur J Cancer ; 94: 168-178, 2018 05.
Article in En | MEDLINE | ID: mdl-29571083
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Biomarkers, Tumor / Transcriptome / Glioma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Biomarkers, Tumor / Transcriptome / Glioma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2018 Document type: Article